Copyright Reports & Markets. All rights reserved.

Global Viscosupplementation for Knee Osteoarthritis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Viscosupplementation for Knee Osteoarthritis
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Viscosupplementation for Knee Osteoarthritis Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Single Injection
    • 1.3.3 Three Injection
    • 1.3.4 Five Injection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Viscosupplementation for Knee Osteoarthritis Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
  • 1.5 Global Viscosupplementation for Knee Osteoarthritis Market Size & Forecast
    • 1.5.1 Global Viscosupplementation for Knee Osteoarthritis Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Viscosupplementation for Knee Osteoarthritis Sales Quantity (2019-2030)
    • 1.5.3 Global Viscosupplementation for Knee Osteoarthritis Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.1.4 Sanofi Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Anika Therapeutics
    • 2.2.1 Anika Therapeutics Details
    • 2.2.2 Anika Therapeutics Major Business
    • 2.2.3 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.2.4 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Anika Therapeutics Recent Developments/Updates
  • 2.3 Seikagaku
    • 2.3.1 Seikagaku Details
    • 2.3.2 Seikagaku Major Business
    • 2.3.3 Seikagaku Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.3.4 Seikagaku Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Seikagaku Recent Developments/Updates
  • 2.4 Zimmer Biomet
    • 2.4.1 Zimmer Biomet Details
    • 2.4.2 Zimmer Biomet Major Business
    • 2.4.3 Zimmer Biomet Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.4.4 Zimmer Biomet Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Zimmer Biomet Recent Developments/Updates
  • 2.5 Bioventus
    • 2.5.1 Bioventus Details
    • 2.5.2 Bioventus Major Business
    • 2.5.3 Bioventus Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.5.4 Bioventus Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bioventus Recent Developments/Updates
  • 2.6 Ferring
    • 2.6.1 Ferring Details
    • 2.6.2 Ferring Major Business
    • 2.6.3 Ferring Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.6.4 Ferring Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ferring Recent Developments/Updates
  • 2.7 LG Chem
    • 2.7.1 LG Chem Details
    • 2.7.2 LG Chem Major Business
    • 2.7.3 LG Chem Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.7.4 LG Chem Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 LG Chem Recent Developments/Updates
  • 2.8 Freda
    • 2.8.1 Freda Details
    • 2.8.2 Freda Major Business
    • 2.8.3 Freda Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.8.4 Freda Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Freda Recent Developments/Updates
  • 2.9 Haohai Biological
    • 2.9.1 Haohai Biological Details
    • 2.9.2 Haohai Biological Major Business
    • 2.9.3 Haohai Biological Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.9.4 Haohai Biological Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Haohai Biological Recent Developments/Updates
  • 2.10 Shanghai Jingfeng
    • 2.10.1 Shanghai Jingfeng Details
    • 2.10.2 Shanghai Jingfeng Major Business
    • 2.10.3 Shanghai Jingfeng Viscosupplementation for Knee Osteoarthritis Product and Services
    • 2.10.4 Shanghai Jingfeng Viscosupplementation for Knee Osteoarthritis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Shanghai Jingfeng Recent Developments/Updates

3 Competitive Environment: Viscosupplementation for Knee Osteoarthritis by Manufacturer

  • 3.1 Global Viscosupplementation for Knee Osteoarthritis Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Manufacturer (2019-2024)
  • 3.3 Global Viscosupplementation for Knee Osteoarthritis Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Viscosupplementation for Knee Osteoarthritis by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Viscosupplementation for Knee Osteoarthritis Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Viscosupplementation for Knee Osteoarthritis Manufacturer Market Share in 2023
  • 3.5 Viscosupplementation for Knee Osteoarthritis Market: Overall Company Footprint Analysis
    • 3.5.1 Viscosupplementation for Knee Osteoarthritis Market: Region Footprint
    • 3.5.2 Viscosupplementation for Knee Osteoarthritis Market: Company Product Type Footprint
    • 3.5.3 Viscosupplementation for Knee Osteoarthritis Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Viscosupplementation for Knee Osteoarthritis Market Size by Region
    • 4.1.1 Global Viscosupplementation for Knee Osteoarthritis Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Viscosupplementation for Knee Osteoarthritis Consumption Value by Region (2019-2030)
    • 4.1.3 Global Viscosupplementation for Knee Osteoarthritis Average Price by Region (2019-2030)
  • 4.2 North America Viscosupplementation for Knee Osteoarthritis Consumption Value (2019-2030)
  • 4.3 Europe Viscosupplementation for Knee Osteoarthritis Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Consumption Value (2019-2030)
  • 4.5 South America Viscosupplementation for Knee Osteoarthritis Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 5.2 Global Viscosupplementation for Knee Osteoarthritis Consumption Value by Type (2019-2030)
  • 5.3 Global Viscosupplementation for Knee Osteoarthritis Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 6.2 Global Viscosupplementation for Knee Osteoarthritis Consumption Value by Application (2019-2030)
  • 6.3 Global Viscosupplementation for Knee Osteoarthritis Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 7.2 North America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 7.3 North America Viscosupplementation for Knee Osteoarthritis Market Size by Country
    • 7.3.1 North America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Viscosupplementation for Knee Osteoarthritis Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 8.2 Europe Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 8.3 Europe Viscosupplementation for Knee Osteoarthritis Market Size by Country
    • 8.3.1 Europe Viscosupplementation for Knee Osteoarthritis Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Viscosupplementation for Knee Osteoarthritis Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Market Size by Region
    • 9.3.1 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Viscosupplementation for Knee Osteoarthritis Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 10.2 South America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 10.3 South America Viscosupplementation for Knee Osteoarthritis Market Size by Country
    • 10.3.1 South America Viscosupplementation for Knee Osteoarthritis Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Viscosupplementation for Knee Osteoarthritis Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Market Size by Country
    • 11.3.1 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Viscosupplementation for Knee Osteoarthritis Market Drivers
  • 12.2 Viscosupplementation for Knee Osteoarthritis Market Restraints
  • 12.3 Viscosupplementation for Knee Osteoarthritis Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Viscosupplementation for Knee Osteoarthritis and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Viscosupplementation for Knee Osteoarthritis
  • 13.3 Viscosupplementation for Knee Osteoarthritis Production Process
  • 13.4 Viscosupplementation for Knee Osteoarthritis Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Viscosupplementation for Knee Osteoarthritis Typical Distributors
  • 14.3 Viscosupplementation for Knee Osteoarthritis Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Viscosupplementation for Knee Osteoarthritis market size was valued at USD 1874.8 million in 2023 and is forecast to a readjusted size of USD 2376.4 million by 2030 with a CAGR of 3.4% during review period.
    Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
    A significant driver in the hyaluronic acid injections for joint pain market is the rising prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Hyaluronic acid injections offer pain relief and improved joint function for individuals suffering from joint pain and osteoarthritis, making them a popular choice. However, a notable challenge in this market is the need for evidence-based research and reimbursement issues. Ensuring the effectiveness of hyaluronic acid injections through clinical studies and addressing reimbursement challenges can be barriers to broader market acceptance. Manufacturers and healthcare providers must collaborate to demonstrate the clinical benefits and cost-effectiveness of these injections to meet the demands of patients seeking non-surgical joint pain management solutions.
    The Global Info Research report includes an overview of the development of the Viscosupplementation for Knee Osteoarthritis industry chain, the market status of Hospital Pharmacies (Single Injection, Three Injection), Retail Pharmacies (Single Injection, Three Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viscosupplementation for Knee Osteoarthritis.
    Regionally, the report analyzes the Viscosupplementation for Knee Osteoarthritis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viscosupplementation for Knee Osteoarthritis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Viscosupplementation for Knee Osteoarthritis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viscosupplementation for Knee Osteoarthritis industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Single Injection, Three Injection).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viscosupplementation for Knee Osteoarthritis market.
    Regional Analysis: The report involves examining the Viscosupplementation for Knee Osteoarthritis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viscosupplementation for Knee Osteoarthritis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Viscosupplementation for Knee Osteoarthritis:
    Company Analysis: Report covers individual Viscosupplementation for Knee Osteoarthritis manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viscosupplementation for Knee Osteoarthritis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
    Technology Analysis: Report covers specific technologies relevant to Viscosupplementation for Knee Osteoarthritis. It assesses the current state, advancements, and potential future developments in Viscosupplementation for Knee Osteoarthritis areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viscosupplementation for Knee Osteoarthritis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Viscosupplementation for Knee Osteoarthritis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Single Injection
    Three Injection
    Five Injection
    Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Major players covered
    Sanofi
    Anika Therapeutics
    Seikagaku
    Zimmer Biomet
    Bioventus
    Ferring
    LG Chem
    Freda
    Haohai Biological
    Shanghai Jingfeng
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Viscosupplementation for Knee Osteoarthritis product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Viscosupplementation for Knee Osteoarthritis, with price, sales, revenue and global market share of Viscosupplementation for Knee Osteoarthritis from 2019 to 2024.
    Chapter 3, the Viscosupplementation for Knee Osteoarthritis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Viscosupplementation for Knee Osteoarthritis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Viscosupplementation for Knee Osteoarthritis market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Viscosupplementation for Knee Osteoarthritis.
    Chapter 14 and 15, to describe Viscosupplementation for Knee Osteoarthritis sales channel, distributors, customers, research findings and conclusion.

    Buy now